Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Third-Generation EGFR Tyrosine Kinase Inhibitor.
about
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Third-Generation EGFR Tyrosine Kinase Inhibitor.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Acquired BRAF V600E Mutation a ...... GFR Tyrosine Kinase Inhibitor.
@en
Acquired BRAF V600E Mutation a ...... GFR Tyrosine Kinase Inhibitor.
@nl
type
label
Acquired BRAF V600E Mutation a ...... GFR Tyrosine Kinase Inhibitor.
@en
Acquired BRAF V600E Mutation a ...... GFR Tyrosine Kinase Inhibitor.
@nl
prefLabel
Acquired BRAF V600E Mutation a ...... GFR Tyrosine Kinase Inhibitor.
@en
Acquired BRAF V600E Mutation a ...... GFR Tyrosine Kinase Inhibitor.
@nl
P1476
Acquired BRAF V600E Mutation a ...... EGFR Tyrosine Kinase Inhibitor
@en
P2093
Elisa De Carlo
Roberto Doliana
P304
P356
10.1016/J.JTHO.2017.07.017
P577
2017-11-01T00:00:00Z